These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 19808478

  • 1. Prediction of ventricular tachyarrhythmias by intracardiac repolarization variability analysis.
    Tereshchenko LG, Fetics BJ, Domitrovich PP, Lindsay BD, Berger RD.
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):276-84. PubMed ID: 19808478
    [Abstract] [Full Text] [Related]

  • 2. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, Multicenter Automatic Defibrillator Implantation Trial II investigators.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1481-7. PubMed ID: 15464332
    [Abstract] [Full Text] [Related]

  • 3. Intracardiac QT integral on far-field ICD electrogram predicts sustained ventricular tachyarrhythmias in ICD patients.
    Tereshchenko LG, Ghanem RN, Abeyratne A, Swerdlow CD.
    Heart Rhythm; 2011 Dec 06; 8(12):1889-94. PubMed ID: 21802390
    [Abstract] [Full Text] [Related]

  • 4. Intracardiac QT variability in patients with structural heart disease on class III antiarrhythmic drugs.
    Tereshchenko LG, Fetics BJ, Berger RD.
    J Electrocardiol; 2009 Dec 06; 42(6):505-10. PubMed ID: 19700170
    [Abstract] [Full Text] [Related]

  • 5. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Iacoviello M, Forleo C, Guida P, Romito R, Sorgente A, Sorrentino S, Catucci S, Mastropasqua F, Pitzalis M.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):225-31. PubMed ID: 17631214
    [Abstract] [Full Text] [Related]

  • 6. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM, TOVA Investigators.
    Circulation; 2004 Mar 23; 109(11):1386-91. PubMed ID: 14993132
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 8. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug 03; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 9. Short-term variability of repolarization predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: a comparison with QT variability index.
    Oosterhoff P, Tereshchenko LG, van der Heyden MA, Ghanem RN, Fetics BJ, Berger RD, Vos MA.
    Heart Rhythm; 2011 Oct 03; 8(10):1584-90. PubMed ID: 21699842
    [Abstract] [Full Text] [Related]

  • 10. Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications.
    Manuchehry A, Agusala K, Montevecchi M, Kadish A, Passman R.
    Pacing Clin Electrophysiol; 2011 May 03; 34(5):571-6. PubMed ID: 21208242
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ, MADIT-II Investigators.
    J Am Coll Cardiol; 2005 Nov 01; 46(9):1712-20. PubMed ID: 16256874
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA, Wichter T, McKenna WJ, Thiene G, Marcus FI.
    Circulation; 2010 Sep 21; 122(12):1144-52. PubMed ID: 20823389
    [Abstract] [Full Text] [Related]

  • 13. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
    Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ.
    Circulation; 2005 Jun 07; 111(22):2898-905. PubMed ID: 15927965
    [Abstract] [Full Text] [Related]

  • 14. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H.
    Int J Cardiol; 2006 Mar 08; 107(3):360-8. PubMed ID: 16503259
    [Abstract] [Full Text] [Related]

  • 15. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia.
    Ngaage DL, Cale AR, Cowen ME, Griffin S, Guvendik L.
    Ann Thorac Surg; 2008 Apr 08; 85(4):1278-81. PubMed ID: 18355509
    [Abstract] [Full Text] [Related]

  • 16. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G.
    Europace; 2008 Mar 08; 10(3):358-63. PubMed ID: 18308756
    [Abstract] [Full Text] [Related]

  • 17. Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator.
    Lunati M, Gasparini M, Bocchiardo M, Curnis A, Landolina M, Carboni A, Luzzi G, Zanotto G, Ravazzi P, Magenta G, Denaro A, Distefano P, Grammatico A, InSync ICD Italian Registry Investigators.
    J Cardiovasc Electrophysiol; 2006 Dec 08; 17(12):1299-306. PubMed ID: 17239095
    [Abstract] [Full Text] [Related]

  • 18. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 08; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 19. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ, PainFREE Rx II Investigators.
    J Am Coll Cardiol; 2005 Jul 19; 46(2):310-6. PubMed ID: 16022960
    [Abstract] [Full Text] [Related]

  • 20. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M, Salerno-Uriarte D, Guzzetti D, Rossi MC, Zoli L, Forzani T, Salerno-Uriarte JA.
    Int J Cardiol; 2005 Oct 20; 105(1):53-7. PubMed ID: 16207545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.